COMMON STOCK OPTIONS AND WARRANTS (Details - Schedule of activity of warrants) - Warrant [Member] - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Outstanding at the beginning of the year | 1,587,553 | 1,521,250 | |
| Outstanding at the beginning of the year | $ 8.62 | $ 8.78 | |
| Outstanding at end of period | 1 year 10 months 24 days | 2 years | 3 years 10 months 24 days |
| Outstanding | |||
| Warrants expired, forfeited, cancelled or exercised | (232,517) | (23,116) | |
| Warrants issued | 21,430 | 89,419 | |
| Warrants issued | $ 7.70 | $ 9.02 | |
| Warrant issued | 1 year 10 months 24 days | 2 years 2 months 12 days | |
| Outstanding at end of period | 1,376,466 | 1,587,553 | 1,521,250 |
| Outstanding at end of period | $ 8.18 | $ 8.62 | $ 8.78 |
| Exercisable at end of period | 1,376,466 | 1,587,553 | |
| Exercisable at end of period | $ 8.18 | $ 8.69 | |
| Exercisable at end of period | 1 year 10 months 24 days | 2 years | |
| Exercisable | |||
| Outstanding at the beginning of the year | 2 years | ||
| X | ||||||||||
- Definition Remaining contractual life beginning. No definition available.
|
| X | ||||||||||
- Definition Warrant issued. No definition available.
|
| X | ||||||||||
- Definition Warrants issued with debt or debt modifications weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|